Evidence map›Paper›PMID 24878112›Full record

Trial reportAIDS care2014

Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.

Stephen J Kerr, Thanyawee Puthanakit, Ung Vibol, Linda Aurpibul, Sophan Vonthanak, Pope Kosalaraksa, Suparat Kanjanavanit, Rawiwan Hansudewechakul, Jurai Wongsawat, Wicharn Luesomboon and 8 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in AIDS care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Frontiers in neuroscience · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stephen J Kerra HIV-NAT , The Thai Red Cross AIDS Research Centre , Bangkok , Thailand.
Thanyawee Puthanakit
Ung Vibol
Linda Aurpibul
Sophan Vonthanak
Pope Kosalaraksa
Suparat Kanjanavanit
Rawiwan Hansudewechakul
Jurai Wongsawat
Wicharn Luesomboon
Kattiya Ratanadilok
Wasana Prasitsuebsai
Kanchana Pruksakaew
Jasper van der Lugt
Robert Paul
Jintanat Ananworanich
Victor Valcour
SEARCH 012 Study Team

Funding

Treatment of HIV/Tuberculosis Co-DiseaseU19AI053741 · NIAID · HIV-NAT, THE THAI RED CROSS AIDS RCH CTR · PI RUXRUNGTHAM, KIAT · 2004 to 2010
$6.3M
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT studyR01MH089722 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALCOUR, VICTOR · 2010 to 2014
$3.1M
NIAID NIH HHS U19 AI053741NIAID NIH HHS U19 AI53741NIMH NIH HHS R01 MH089722
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV)-negative children born to HIV-infected mothers may exhibit differences in neurodevelopment (ND) compared to age- and gender-matched controls whose lives have not been affected by HIV. This could occur due to exposure to HIV and antiretroviral agents in utero and perinatally, or differences in the environment in which they grow up. This study assessed neurodevelopmental outcomes in HIV-exposed uninfected (HEU) and HIV-unexposed uninfected (HUU) children enrolled as controls in a multicenter ND study from Thailand and Cambodia. One hundred sixty HEU and 167 HUU children completed a neurodevelopmental assessment using the Beery Visual Motor Integration (VMI) test, Color Trails, Perdue Pegboard, and Child Behavior Checklist (CBCL). Thai children (n = 202) also completed the Wechsler Intelligence Scale (IQ) and Stanford-Binet II memory tests. In analyses adjusted for caregiver education, parent as caregiver, household income, age, and ethnicity, statistically significant lower scores were seen on verbal IQ (VIQ), full-scale IQ (FSIQ), and Binet Bead Memory among HEU compared to HUU. The mean (95% CI) differences were -6.13 (-10.3 to -1.96), p = 0.004; -4.57 (-8.80 to -0.35), p = 0.03; and -3.72 (-6.57 to -0.88), p = 0.01 for VIQ, FSIQ, and Binet Bead Memory, respectively. We observed no significant differences in performance IQ, other Binet memory domains, Color Trail, Perdue Pegboard, Beery VMI, or CBCL test scores. We conclude that HEU children evidence reductions in some neurodevelopmental outcomes compared to HUU; however, these differences are small and it remains unclear to what extent they have immediate and long-term clinical significance.

Indexed as

Child DevelopmentAnti-Retroviral AgentsCambodiaCase-Control StudiesChildChild, PreschoolCognitionEnzyme-Linked Immunosorbent AssayFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalIntelligence TestsMaleAnti-Retroviral AgentschildrenHIVneurodevelopmentresource-limited setting

Identifiers

PMID24878112
PMCPMC4122621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.